Orchestra BioMed Holdings (OBIO) Prepaid Assets (2020 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Prepaid Assets of $1.4 million for Q1 2026, down 19.33% year-over-year from $1.8 million in Q1 2025, and up 45.67% quarter-over-quarter from $994000.0 in Q4 2025.
Analysis
Orchestra BioMed Holdings (OBIO) Prepaid Assets (2020 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Prepaid Assets for 7 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 19.33% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 19.33% YoY), while the FY2025 annual figure was $994000.0, down 52.53% from the prior year.
- Prepaid Assets grew to $1.4 million in Q1 2026 per OBIO's latest filing, from $994000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $2.3 million in Q1 2023 and bottomed at $36417.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $1.2 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 65.54% — and 2023, when it soared 3931.08%.
- Orchestra BioMed Holdings' Prepaid Assets stood at $533000.0 in 2022, then jumped by 139.02% to $1.3 million in 2023, then jumped by 64.36% to $2.1 million in 2024, then plunged by 52.53% to $994000.0 in 2025, then surged by 45.67% to $1.4 million in 2026.
- Business Quant data shows OBIO's Prepaid Assets at $1.4 million in Q1 2026, $994000.0 in Q4 2025, and $1.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 977,000.00 |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 994,000.00 |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 533,000.00 |
| Sep 30, 2022 | 137,338.00 |
| Jun 30, 2022 | 36,417.00 |
| Mar 31, 2022 | 71,292.00 |
| Dec 31, 2021 | 46,667.00 |
| Sep 30, 2021 | 81,167.00 |